{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:15:29Z","timestamp":1776903329527,"version":"3.51.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T00:00:00Z","timestamp":1247443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T00:00:00Z","timestamp":1247443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/bmt.2009.165","type":"journal-article","created":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T15:34:44Z","timestamp":1247499284000},"page":"311-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group"],"prefix":"10.1038","volume":"45","author":[{"given":"A","family":"Numata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Kamezaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Takase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Henzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nagafuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Fukuoka Blood and Marrow Transplantation Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,13]]},"reference":[{"key":"BFbmt2009165_CR1","first-page":"351P","volume-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES . Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press: Lyon, Washington DC, 2001, 351P pp."},{"key":"BFbmt2009165_CR2","doi-asserted-by":"crossref","unstructured":"Jaffe ES . Pathobiology of peripheral T-cell lymphomas. Hematology Am Soc Hematol Educ Program 2006, 317\u2013322.","DOI":"10.1182\/asheducation-2006.1.317"},{"key":"BFbmt2009165_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/sj.bmt.1705649","volume":"39","author":"K Kamezaki","year":"2007","unstructured":"Kamezaki K, Kikushige Y, Numata A, Miyamoto T, Takase K, Henzan H et al. Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma. Bone Marrow Transplant 2007; 39: 523\u2013527.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009165_CR4","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1200\/JCO.2000.18.16.3025","volume":"18","author":"C Haioun","year":"2000","unstructured":"Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P et al. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study. J Clin Oncol 2000; 18: 3025\u20133030.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009165_CR5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa031770","volume":"350","author":"N Milpied","year":"2004","unstructured":"Milpied N, Deconinck E, Gaillard F, Delwail V, Foussard C, Berthou C et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004; 350: 1287\u20131295.","journal-title":"N Engl J Med"},{"key":"BFbmt2009165_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B","volume":"63","author":"JO Armitage","year":"1989","unstructured":"Armitage JO, Greer JP, Levine AM, Weisenburger DD, Formenti SC, Bast M et al. Peripheral T-cell lymphoma. Cancer 1989; 63: 158\u2013163.","journal-title":"Cancer"},{"key":"BFbmt2009165_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","volume":"1","author":"B Coiffier","year":"1990","unstructured":"Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives). Ann Oncol 1990; 1: 45\u201350.","journal-title":"Ann Oncol"},{"key":"BFbmt2009165_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J et al. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol 2007; 18: 652\u2013657.","journal-title":"Ann Oncol"},{"key":"BFbmt2009165_CR9","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/annonc\/mdh471","volume":"15","author":"N Mounier","year":"2004","unstructured":"Mounier N, Gisselbrecht C, Briere J, Haioun C, Feugier P, Offner F et al. All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Ann Oncol 2004; 15: 1790\u20131797.","journal-title":"Ann Oncol"},{"key":"BFbmt2009165_CR10","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","volume":"20","author":"P Corradini","year":"2006","unstructured":"Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006; 20: 1533\u20131538.","journal-title":"Leukemia"},{"key":"BFbmt2009165_CR11","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7: 1630\u20131636.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009165_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"A predictive model for aggressive non-Hodgkin's lymphoma","year":"1993","unstructured":"A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987\u2013994.","journal-title":"N Engl J Med"},{"key":"BFbmt2009165_CR13","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","year":"1997","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909\u20133918.","journal-title":"Blood"},{"key":"BFbmt2009165_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.bbmt.2008.04.004","volume":"14","author":"AI Chen","year":"2008","unstructured":"Chen AI, McMillan A, Negrin RS, Horning SJ, Laport GG . Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience. Biol Blood Marrow Transplant 2008; 14: 741\u2013747.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009165_CR15","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998; 92: 76\u201382.","journal-title":"Blood"},{"key":"BFbmt2009165_CR16","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/cncr.20999","volume":"103","author":"MP Escalon","year":"2005","unstructured":"Escalon MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL et al. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M D Anderson Cancer Center experience. Cancer 2005; 103: 2091\u20132098.","journal-title":"Cancer"},{"key":"BFbmt2009165_CR17","doi-asserted-by":"crossref","unstructured":"Greer JP . Therapy of peripheral T\/NK neoplasms. Hematology Am Soc Hematol Educ Program 2006, 331\u2013337.","DOI":"10.1182\/asheducation-2006.1.331"},{"key":"BFbmt2009165_CR18","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540\u20131545.","journal-title":"N Engl J Med"},{"key":"BFbmt2009165_CR19","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/annonc\/mdg459","volume":"14","author":"J Rodriguez","year":"2003","unstructured":"Rodriguez J, Caballero MD, Gutierrez A, Marin J, Lahuerta JJ, Sureda A et al. High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience. Ann Oncol 2003; 14: 1768\u20131775.","journal-title":"Ann Oncol"},{"key":"BFbmt2009165_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.bmt.1701596","volume":"23","author":"R Fanin","year":"1999","unstructured":"Fanin R, Ruiz de Elvira MC, Sperotto A, Baccarani M, Goldstone A . Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1999; 23: 437\u2013442.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009165_CR21","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1080\/10428190412331272749","volume":"45","author":"M Jagasia","year":"2004","unstructured":"Jagasia M, Morgan D, Goodman S, Hamilton K, Kinney M, Shyr Y et al. Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant. Leuk Lymphoma 2004; 45: 2261\u20132267.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2009165_CR22","first-page":"3060","volume":"108","author":"AP Nademanee","year":"2006","unstructured":"Nademanee AP, Zain JM, Palmer J, Tsai N, Kogut NM, Krishnan A et al. The impact of disease status on the outcome of high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) for peripheral T-cell lymphoma (PTCL). ASH Annu Meeting Abstr 2006; 108: 3060.","journal-title":"ASH Annu Meeting Abstr"},{"key":"BFbmt2009165_CR23","first-page":"1892","volume":"110","author":"D-H Yang","year":"2007","unstructured":"Yang D-H, Kim WS, Kim SJ, Bae SH, Kim SH, Kim IH et al. The clinical outcomes of autologous stem cell transplantation in peripheral T cell lymphoma: from Retrospective Multicenter Study in Korea. ASH Annu Meet Abstr 2007; 110: 1892.","journal-title":"ASH Annu Meet Abstr"},{"key":"BFbmt2009165_CR24","first-page":"1372","volume":"88","author":"J Rodriguez","year":"2003","unstructured":"Rodriguez J, Caballero MD, Gutierrez A, Gandarillas M, Sierra J, Lopez-Guillermo A et al. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy.The GEL-TAMO experience. Haematologica 2003; 88: 1372\u20131377.","journal-title":"Haematologica"},{"key":"BFbmt2009165_CR25","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/annonc\/mdn022","volume":"19","author":"S Mercadal","year":"2008","unstructured":"Mercadal S, Briones J, Xicoy B, Pedro C, Escoda L, Estany C et al. Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol 2008; 19: 958\u2013963.","journal-title":"Ann Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2009165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:12:14Z","timestamp":1648037534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2009165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,13]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFbmt2009165"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.165","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,13]]},"assertion":[{"value":"14 October 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}